Back to search

Article

Enhancing Anti-Angiogenic Therapy with Bevacizumab-Loaded Nanoflowers Through The Chorioallantoic Membrane Assay

2024-12-02

Abstract excerpt

<title>Abstract</title> <p>Discovering new cancer treatments is crucial, especially to counteract how tumors grow and spread through angiogenesis. This study proposes a novel method using Bevacizumab-loaded nanoflowers (Beva-NF), designed to enhance the anti-VEGF effects of Bevacizumab in a more targeted and effective way. By incorporating Bevacizumab into nanostructures, we aimed to address the limitations of co...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
18134567-0e70-57a3-bb47-f09c160955c8
DOI
10.21203/rs.3.rs-5430745/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Enhancing Anti-Angiogenic Therapy with Bevacizumab-Loaded Nanoflowers Through The Chorioallantoic Membrane AssayDOI 10.21203/rs.3.rs-5430745/v1
Select a neighboring publication to make it the new centre.